FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Sakoulas

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Pamela A Moise; Mohamad Rashid; Maria Amodio-Groton; Holly L Hoffman-Roberts; Kenneth C Lamp; George Sakoulas; Suzanne Schweitzer; Min J Yoon; Anjay Rastogi
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Brian J Werth; Joseph Pogliano; Warren E Rose; George Sakoulas; Ryan Tewhey; Michael J Rybak
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
Jose Orsini; Nina Cohen; Niraj Karki; Carlo Mainardi; Eliza Muzylo; George Sakoulas
Microbiological profile of organisms causing bloodstream infection in critically ill patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Sakoulas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pamela A Moise; Mohamad Rashid; Maria Amodio-Groton; Holly L Hoffman-Roberts; Kenneth C Lamp; George Sakoulas; Suzanne Schweitzer; Min J Yoon; Anjay Rastogi
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Antimicrobial agents and chemotherapy 2013;57(3):1192-200.
2013: Brian J Werth; Joseph Pogliano; Warren E Rose; George Sakoulas; Ryan Tewhey; Michael J Rybak
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
Antimicrobial agents and chemotherapy 2013;57(1):66-73.
2012: Jose Orsini; Nina Cohen; Niraj Karki; Carlo Mainardi; Eliza Muzylo; George Sakoulas
Microbiological profile of organisms causing bloodstream infection in critically ill patients.
Journal of clinical medicine research 2012;4(6):371-7.
2012: Nina M Haste; William Fenical; Paul R Jensen; Sandra Loesgen; Sang-Jip Nam; Victor Nizet; George Sakoulas; Peng Sun; Wdee Thienphrapa; Dan N Tran; Mary E Hensler
Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.
The Journal of antibiotics 2012;65(12):593-8.
2012: Warren E Rose; Sanjay K Shukla; Sara E Cosgrove; Jens C Eickhoff; Victor Nizet; Madhulatha Pantrangi; Suzan Rooijakkers; George Sakoulas
Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.
The Journal of infectious diseases 2012;206(10):1604-11.
2012: Romney M Humphries; THEODOROS KELESIDIS; Victor Nizet; Warren E Rose; Nicholas Schork; Ryan Tewhey; George Sakoulas
Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 2012;56(11):6051-3.
2012: Nagendra N Mishra; Pamela A Moise; Arnold S Bayer; Michael R Yeaman; George Sakoulas
Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.
The Journal of infectious diseases 2012;206(8):1160-7.
2012: Andrew D Berti; Gary G Girdaukas; Scott J Hetzel; George Sakoulas; Justine E Wergin; Warren E Rose
Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.
Antimicrobial agents and chemotherapy 2012;56(10):5046-53.
2012: Shauna M McGillivray; John N Alumasa; Kenneth C Keiler; Cheryl Y Okumura; Nitya S Ramadoss; George Sakoulas; Dan N Tran; Micah M Vaughn; Dawn X Zhang; Victor Nizet
Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics.
Antimicrobial agents and chemotherapy 2012;56(4):1854-61.
2012: George Sakoulas; Brian T Tsuji; Soo-Jin Yang; Michael R Yeaman; Arnold S Bayer; Nagendra N Mishra; Victor Nizet; Joseph Pogliano; Pamela A Moise
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 2012;56(2):838-44.
2012: Abhay Dhand; George Sakoulas
Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.
F1000 medicine reports 2012;4():4.
2012: George Sakoulas; William Fenical; Paul R Jensen; Sandra Loesgen; Sang-Jip Nam; Victor Nizet; Mary E Hensler
Novel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureus.
PloS one 2012;7(1):e29439.
2011: Carla J Walraven; Paulina Deming; Lisa Marr-Lyon; Michael S North; George Sakoulas; Renée-Claude Mercier
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
The Journal of antimicrobial chemotherapy 2011;66(10):2386-92.
2011: Adrien Fischer; Arnold S Bayer; Myriam Girard; Sébastien Herzig; Richard A Proctor; George Sakoulas; Alexander Scherl; Jacques Schrenzel; Ludwig Stenz; Ali R Vaezzadeh; Soo-Jin Yang; Michael R Yeaman; Patrice Francois
Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.
The Journal of antimicrobial chemotherapy 2011;66(8):1696-711.
2011: Abhay Dhand; Victor Nizet; Joseph Pogliano; Arnold S Bayer; Michael Bolaris; Guiquing Wang; Soo-Jin Yang; George Sakoulas
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(2):158-63.
2011: Ravina Kullar; Donald P Levine; Sara E Cosgrove; Christopher W Crank; Susan Leroque Davis; George Sakoulas; John Segreti; Jing J Zhao; Michael J Rybak
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
Pharmacotherapy 2011;31(6):527-36.
2011: Marin L Schweizer; Jon P Furuno; George Sakoulas; Jennifer K Johnson; Anthony D Harris; Michelle D Shardell; Jessina McGregor; Kerri A Thom; Eli N Perencevich
Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients.
Antimicrobial agents and chemotherapy 2011;55(3):1082-7.
2011: Kati Seidl; Arnold S Bayer; Vance G Fowler; James A McKinnell; Wessam Abdel Hady; George Sakoulas; Michael Yeaman; Yan-Qiong Xiong
Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.
Antimicrobial agents and chemotherapy 2011;55(2):575-82.
2011: Marin L Schweizer; Michelle D Shardell; Kerri A Thom; George Sakoulas; Sara E Cosgrove; Jon P Furuno; Anthony D Harris; Jennifer K Johnson; Jessina McGregor; Eli N Perencevich
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
BMC infectious diseases 2011;11():279.
2010: Jennifer Le; P Brandon Bookstaver; Celeste N Rudisill; Mohamed G Hashem; Raza Iqbal; Charles L James; George Sakoulas
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
The Annals of pharmacotherapy 2010;44(12):2001-6.
2010: Agnes Wong; Shilpa P Reddy; Davida S Smyth; Maria E Aguero-Rosenfeld; George Sakoulas; D Ashley Robinson
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
Antimicrobial agents and chemotherapy 2010;54(2):742-8.
2010: Pamela A Moise; Alan Forrest; Arnold S Bayer; Yan Q Xiong; Michael Yeaman; George Sakoulas
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.
The Journal of infectious diseases 2010;201(2):233-40.
2010: Marin L Schweizer; Jon P Furuno; Anthony D Harris; Jennifer K Johnson; Michelle D Shardell; Jessina McGregor; Kerri A Thom; George Sakoulas; Eli N Perencevich
Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.
PloS one 2010;5(7):e11432.
2009: Soo-Jin Yang; Barry N Kreiswirth; George Sakoulas; Michael Yeaman; Yan-Qiong Xiong; Ayumi Sawa; Arnold S Bayer
Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.
The Journal of infectious diseases 2009;200(12):1916-20.
2009: George Sakoulas
Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15 Suppl 6():11-6.
2009: Patricia Dandache; Pamela A Moise; Jose Orsini; Marisa A Montecalvo; George Sakoulas
Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci.
The Journal of antimicrobial chemotherapy 2009;64(5):1114-5.
2009: Pamela A Moise; Donald North; Judith N Steenbergen; George Sakoulas
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
The Lancet infectious diseases 2009;9(10):617-24.
2009: Kerry L LaPlante; George Sakoulas
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Antimicrobial agents and chemotherapy 2009;53(10):4549-55.
2009: George Sakoulas; Gary P Wormser; Paul Visintainer; Wilbert S Aronow; Robert B Nadelman
Relationship between population density of attorneys and prevalence of methicillin-resistant Staphylococcus aureus: is medical-legal pressure on physicians a driving force behind the development of antibiotic resistance?
American journal of therapeutics 2009;16(5):e1-6.
2009: George Sakoulas; Jack Brown; Kenneth C Lamp; Lawrence V Friedrich; Kimberly C Lindfield
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Clinical therapeutics 2009;31(9):1936-45.
2009: Yoriko Harigaya; Jürgen Bulitta; Alan Forrest; George Sakoulas; Alan J Lesse; Joseph M Mylotte; Brian T Tsuji
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.
Antimicrobial agents and chemotherapy 2009;53(9):3894-901.
2009: Brian T Tsuji; Yoriko Harigaya; Alan J Lesse; George Sakoulas; Joseph M Mylotte
Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density.
Diagnostic microbiology and infectious disease 2009;64(2):220-4.
2009: George Sakoulas; Pamela A Moise; Michael J Rybak
Accessory gene regulator dysfunction: an advantage for Staphylococcus aureus in health-care settings?
The Journal of infectious diseases 2009;199(10):1558-9.
2009: Pamela A Moise; Davida S Smyth; D Ashley Robinson; Nadia El-Fawal; Carlo McCalla; George Sakoulas
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies.
The Journal of antimicrobial chemotherapy 2009;63(5):873-6.
2009: Avisheh Forouzesh; Pamela A Moise; George Sakoulas
Vancomycin ototoxicity: a reevaluation in an era of increasing doses.
Antimicrobial agents and chemotherapy 2009;53(2):483-6.
2009: Jose Orsini; J Nowakowski; V Delaney; George Sakoulas; Gary P Wormser
Cryptococcal infection presenting as cellulitis in a renal transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(1):68-71.
2008: George Sakoulas
Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
Clinical advances in hematology & oncology : H&O 2008;6(11):813-5.
2008: Carlo McCalla; Davida S Smyth; D Ashley Robinson; Judith Steenbergen; Steven A Luperchio; Pamela A Moise; Vance G Fowler; George Sakoulas
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Antimicrobial agents and chemotherapy 2008;52(9):3441-3.
2008: Tahaniyat Lalani; Jerome J Federspiel; Helen W Boucher; Thomas H Rude; In-Gyu Bae; Michael J Rybak; Giang T Tonthat; G Ralph Corey; Martin E Stryjewski; George Sakoulas; Vivian H Chu; Jeff Alder; Judith N Steenbergen; Steven A Luperchio; Marilyn Campion; Christopher W Woods; Vance G Fowler
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
Journal of clinical microbiology 2008;46(9):2890-6.
2008: Zukile Gqada; Ben Marais; Elizabeth Wasserman; Colleen Bamford; Heidi Orth; George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(7):2471; author reply 2471-2.
2008: George Sakoulas; Robert C Moellering
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46 Suppl 5():S360-7.
2008: Warren E Rose; Glenn W Kaatz; George Sakoulas; Michael J Rybak
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model.
The Journal of antimicrobial chemotherapy 2008;61(5):1099-102.
2008: Pamela A Moise; Rochelle S Castro; Caroline Sul; Alan Forrest; George Sakoulas
Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
The Annals of pharmacotherapy 2008;42(4):592-3.
2008: Warren E Rose; Steven N Leonard; George Sakoulas; Glenn W Kaatz; Marcus Zervos; Anjly Sheth; Christopher F Carpenter; Michael J Rybak
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Antimicrobial agents and chemotherapy 2008;52(3):831-6.
2008: Pamela A Moise; Davida S Smyth; Nadia El-Fawal; D Ashley Robinson; Patricia N Holden; Alan Forrest; George Sakoulas
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
The Journal of antimicrobial chemotherapy 2008;61(1):85-90.
2008: George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(1):220-4.
2008: Tiffanny Jones; Michael Yeaman; George Sakoulas; Soo-Jin Yang; Richard A Proctor; Hans-Georg Sahl; Jacques Schrenzel; Yan-Qiong Xiong; Arnold S Bayer
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.
Antimicrobial agents and chemotherapy 2008;52(1):269-78.
2007: George Sakoulas; Yoav Golan; Kenneth C Lamp; Lawrence V Friedrich; Rene Russo
Daptomycin in the treatment of bacteremia.
The American journal of medicine 2007;120(10 Suppl 1):S21-7.
2007: Helen W Boucher; George Sakoulas
Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(5):601-8.
2007: Pamela A Moise; George Sakoulas; Alan Forrest; Jerome J Schentag
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
Antimicrobial agents and chemotherapy 2007;51(7):2582-6.
2007: Warren E Rose; Michael J Rybak; Brian T Tsuji; Glenn W Kaatz; George Sakoulas
Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
The Journal of antimicrobial chemotherapy 2007;59(6):1190-3.
2007: Satish K Pillai; Howard S Gold; George Sakoulas; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Antimicrobial agents and chemotherapy 2007;51(6):2223-5.
2007: Brian T Tsuji; Michael J Rybak; Kerry L Lau; George Sakoulas
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2007;51(3):1089-91.
2007: Patricia Dandache; Wilbert S Aronow; George Sakoulas
Clinical update on the diagnosis and treatment of bacterial endocarditis.
Comprehensive therapy 2007;33(4):192-207.
2006: George Sakoulas; Jeff Alder; Claudie Thauvin-Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Antimicrobial agents and chemotherapy 2006;50(4):1581-5.
2006: George Sakoulas; Howard S Gold; Robert A Cohen; Lata Venkataraman; Robert C Moellering; George Miltiades Eliopoulos
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
The Journal of antimicrobial chemotherapy 2006;57(4):699-704.
2006: George Sakoulas; Robert C Moellering; George Miltiades Eliopoulos
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42 Suppl 1():S40-50.
2005: George Sakoulas; George Miltiades Eliopoulos; Vance G Fowler; Robert C Moellering; Richard novick; Natalie Lucindo; Michael Yeaman; Arnold S Bayer
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
Antimicrobial agents and chemotherapy 2005;49(7):2687-92.
2004: Vance G Fowler; George Sakoulas; Lauren M McIntyre; Venkata G Meka; Robert D Arbeit; Christopher H Cabell; Martin E Stryjewski; George Miltiades Eliopoulos; L Barth Reller; G Ralph Corey; Tiffanny Jones; Natalie Lucindo; Michael Yeaman; Arnold S Bayer
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
The Journal of infectious diseases 2004;190(6):1140-9.
2004: Satish K Pillai; George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Barbara E Murray; Roger T Inouye
Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis.
The Journal of infectious diseases 2004;190(5):967-70.
2004: Venkata G Meka; Satish K Pillai; George Sakoulas; Christine Wennersten; Lata Venkataraman; Paola C DeGirolami; George Miltiades Eliopoulos; Robert C Moellering; Howard S Gold
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
The Journal of infectious diseases 2004;190(2):311-7.
2004: Pamela A Moise-Broder; George Sakoulas; George Miltiades Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(12):1700-5.
2004: George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George Miltiades Eliopoulos
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Journal of clinical microbiology 2004;42(6):2398-402.
2004: Philip E Tarr; George Sakoulas; Anuradha Ganesan; Margo A Smith; Daniel R Lucey
Hematogenous enterococcal vertebral osteomyelitis: report of 2 cases and review of the literature.
The Journal of infection 2004;48(4):354-62.
2004: Christopher W Woods; Allen C Cheng; Vance G Fowler; Mary Moorefield; Joyce Frederick; George Sakoulas; Venkata G Meka; Fred C Tenover; Peter Zwadyk; Kenneth H Wilson
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(8):1188-91.
2003: Mitchell J Schwaber; Sharon B Wright; Yehuda Carmeli; Lata Venkataraman; Paola C DeGirolami; Aneta Gramatikova; Trish M Perl; George Sakoulas; Howard S Gold
Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.
Emerging infectious diseases 2003;9(6):657-64.
2003: George Sakoulas; George Miltiades Eliopoulos; Jeff Alder; Claudie Thauvin Eliopoulos
Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2003;47(5):1714-8.
2003: George Sakoulas; Howard S Gold; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro; George Miltiades Eliopoulos
Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.
The Journal of antimicrobial chemotherapy 2003;51(4):1039-41.
2003: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Richard novick; Lata Venkataraman; Christine Wennersten; Paola C DeGirolami; Mitchell J Schwaber; Howard S Gold
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?
The Journal of infectious diseases 2003;187(6):929-38.
2003: Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(1):53-9.
2002: Satish K Pillai; George Sakoulas; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Mary Jane Ferraro; Howard S Gold
Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
The Journal of infectious diseases 2002;186(11):1603-7.
2002: Satish K Pillai; George Sakoulas; Howard S Gold; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Roger T Inouye
Prevalence of the fsr locus in Enterococcus faecalis infections.
Journal of clinical microbiology 2002;40(7):2651-2.
2002: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard novick; Howard S Gold
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Antimicrobial agents and chemotherapy 2002;46(5):1492-502.
2001: George Sakoulas; Howard S Gold; Lata Venkataraman; Paola C DeGirolami; George Miltiades Eliopoulos; Q Qian
Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
Journal of clinical microbiology 2001;39(11):3946-51.
2001: S Tsiodras; Howard S Gold; George Sakoulas; George Miltiades Eliopoulos; Christine Wennersten; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Lancet 2001;358(9277):207-8.
2001: George Sakoulas; Paola C DeGirolami; Howard S Gold
Methicillin-susceptible Staphylococcus aureus: believe it, or not.
Archives of internal medicine 2001;161(9):1237-8.
2001: George Sakoulas
Brainstem and striatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin.
The Pediatric infectious disease journal 2001;20(5):543-5.
1997: George Sakoulas; Nicholas A Tritos; M Lally; Christine Wanke; Pamela I Hartzband
Hypercalcemia in an AIDS patient treated with growth hormone.
AIDS (London, England) 1997;11(11):1353-6.